Vés al contingut

A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS EFFICACY AND SAFETY OF OMECAMTIV MECARBIL IN PATIENTS WITH SYMPTOMATIC HEART FAILURE WITH SEVERELY REDUCED EJECTION FRACTION

Obert
  • Codi protocol: CY 1033
  • Codi EudraCT: No aplica
  • Grup de recerca: Malalties Cardiovasculars
  • Servei: Cardiologia
  • Investigador/a principal:  Méndez Fernández, Ana Belén
  • Malaltia: Malalties del sistema circulatori
  • Fase: Fase III